ꢀ
446
X. Alvarez-Mic o´ et al. / Carbohydrate Research 342 (2007) 440–447
1
5
.00 (d, 1H, J 11 Hz, H–CH ), 5.46 (d, 1H, J 3.5 Hz,
b-Anomer (minor byproduct): H NMR (250 MHz,
2
1–2
H-1), 7.02–7.11 (ddd, 1H, J4
0
0
1:2,
J
0
0
7:4,
CDCl ): d 3.53–3.70 (m, 2H, H-6), 3.76–3.78 (m, 1H,
H-5), 4.10–4.15 (dd, 1H, J3–4 3.9, J3–2 7.6 Hz, H-3),
–6
4 –5
3
0
0
J4
0
0
8:4 Hz, H-4 ), 7.13–7.37 (m, 21H, H-6 , H-2Ar,
–3
H-3Ar, H-4Ar), 7.38–7.45 (ddd, 1H, J5
0
0
1:7,
4.29–4.61 (m, 9H, H-2, H-2, H–CH ), 4.69 (d, 1H, J
–3
2
0
J5
J3
0
0
7:4,
J
0
0
9:1 Hz, H-5 ), 7.80–7.84 (dd, 1H,
8:4 Hz, H-3 ); C NMR (62.9 MHz,
11.8 Hz, H–CH ), 5.66 (1H, J
1.2 Hz, H-1), 7.04–
–4
5 –6
2
1–2
0
13
0
0
0
1:7, J
0
0
7.11 (ddd, 1H, J
0
0
1 Hz, J
0
0
7:1, J
0
0
8:1 Hz, H-4 ),
–5
3 –4
4 –6
4 –5
4 –3
CDCl ): d 68.2 (C-6), 71.9 (C-5), 73.4, 73.5, 74.9, 75.9
7.12–7.43 (m, 22H, H-2Ar, H-3Ar, H-4Ar), 7.78–7.82
3
0
13
(
C–CH ), 77.1 (C-4), 79.8 (C-2), 81.5 (C-3), 96.9 (C-1),
(dd, 1H, J
0
0
1:7, J 8:1 Hz, H-3 );
0 0
C NMR
2
3 –5
3 –4
0
0
0
1
17.1 (C-6 ), 121.8 (C-4 ), 125.4 (C-3 ), 127.6, 127.7,
(62.9 MHz, CDCl ): d 70.5 (C-6), 72.2, 72.5, 73.4, 75.5
3
1
27.8, 128.9, 128.1, 128.3, 128.4, 128.5 (C-2Ar, C-3Ar,
(·2) (C–CH ) (C-5), 82.1 (C-4), 82.3 (C-3), 88.5 (C-2),
2
0
0
0
0
C-4Ar), 133.8 (C-5 ), 137.7, 138.2, 138.3, 138.7 (C-1Ar),
1
106.4 (C-1), 119.4 (C-6 ), 122.2 (C-4 ), 125.5 (C-3 ),
127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.1, 128.33,
128.37, 128.36, 128.39, 128.4 (C-2Ar, C-3Ar, C-4Ar),
0
0
40.8 (C-2 ), 149.9 (C-1 ); MALDI-TOFMS: m/z 684.6
+
[
M+Na] . Anal. Calcd for C H NO : C, 72.60; H,
40 39 8
0
5
.94; N, 2.12. Found: C, 72.98; H, 5.84; N, 2.09.
133.7 (C-5 ), 137.3, 137.6, 138.1, 138.2 (C-1Ar), 141.3
1
0
0
b-Anomer (minor byproduct): H NMR (250 MHz,
(C-2 ), 149.8 (C-1 ); MALDI-TOFMS: m/z 684.0
+
CDCl ): d 3.55–3.87 (m, 6H, H-2, H-3, H-4, H-5, H-
[M+Na] .
3
6
), 4.45–4.58 (m, 3H, H–CH ), 4.77–4.85 (m, 3H, H–
2
CH ), 4.97 (d, 1H, J 11 Hz, H–CH ), 5.04 (d, 1H, J
3.11. 2-Nitrophenyl 2,3,4,6-tetra-O-benzyl-a-D-manno-
pyranoside (4c)
2
2
1
7
4
1 Hz, H–CH ), 5.11 (d, 1H, J
.50 (m, 23H, H-4 , H-5 , H-6 , H-2 Ar, H-3 Ar, H-
7 Hz, H-1), 7.15–
1–2
2
0
0
0
0
13
Ar), 7.83 (d, 1H, J3
0
0
7:9 Hz, H-3 );
C NMR
Treatment of 1h (0.5 g, 0.92 mmol), NaH (44 mg) and 2b
(0.17 g, 1.1 mmol) as described for 3a afforded 4c
–4
(
62.9 MHz, CDCl ): d 68.9 (C-6), 73.5 (C-5), 75.1,
3
2
D
0
1
7
5.2, 75.5, 75.8 (C–CH ), 77.5 (C-2), 81.6 (C-4), 84.6
(0.53 g; 89%); ½aꢀ +59.7 (c 1, CHCl3); H NMR
2
0
0
(
C-3), 100.9 (C-1), 117.1 (C-6 ), 122.0 (C-4 ), 125.4
(250 MHz, CDCl ): d 3.66–3.71 (dd, 1H, J
2.2,
6a–5
3
0
(
C-3 ), 127.7, 127.8, 127.9, 128.0, 128.3, 128.4, 128.5
J6a–5 10.8 Hz, H-6a), 3.73–3.80 (dd, 1H, J6b–5 4.9, J6b–5
(
1
6
C-2Ar, C-3 Ar, C-4 Ar), 133.9, 137.8, 137.9, 138.4 (C-
11.1 Hz, H-6b), 3.89–4.13 (m, 4H, H-2, H-3, H-4, H-
0
0
Ar), 140.5 (C-2 ), 150.1 (C-1 ); MALDI-TOFMS: m/z
5), 4.46 (d, 1H, J 11.8 Hz, H–CH ), 4.52 (d, 1H, J
2
+
84.6 [M+Na] .
11.1 Hz, H–CH ), 4.60 (d, 1H, J 11.8 Hz, H–CH ),
2
2
3
.67–4.75 (m, 3H, H–CH ), 4.81 (d, 1H, J 12.1 Hz, H–
2
3.10. 2-Nitrophenyl 2,3,4,6-tetra-O-benzyl-D-galacto-
pyranoside (4b)
CH ), 4.89 (d, 1H, J 11.1 Hz, H–CH ), 5.57 (d, 1H,
2 2
J1–2 2.0 Hz, H-1), 7.04–7.12 (ddd, 1H, J
0
0
1:7,
4 –6
0
J4
0
0
6:7, J
0
0
8:1 Hz, H-4 ), 7.16–7.45 (m, 22H, H-
–5
4 –3
Treatment of 1g (0.5 g, 0.92 mmol), NaH (44 mg) and 2b
2Ar, H-3Ar, H-4Ar), 7.78–7.83 (dd, 1H, J
0
0
1:4,
3 –5
0
13
(
(
0.17 g, 1.1 mmol) as described for 3a afforded 4b
0.55 g; 92%; a/b 3:1).
J3
0
0
8:1 Hz, H-3 ); C NMR (62.9 MHz, CDCl ): d
69.1 (C-6), 72.7, 73.2 (C–CH ), 73.3 (C-5, C–CH ),
74.4 (C-4), 74.8 (C-2), 75.0 (C–CH ), 79.6 (C-3), 98.3
2
(C-1), 118.7 (C-6 ), 122.3 (C-4 ), 125.4 (C-3 ), 127.5,
127.6, 127.7, 127.8, 127.9, 128.1, 128.2, 128.3, 128.4,
128.5 (C-2Ar, C-3Ar, C-4Ar), 134.1 (C-5 ), 138.1,
138.2 (·2), 138.4 (C-1Ar), 140.7 (C-2 ), 149.7 (C-1 );
MALDI-TOFMS: m/z 684.0 [M+Na] . Anal. Calcd
–4
3
2
2
20
1
a-Anomer: ½aꢀ +129 (c 0.75, CHCl3); H NMR
D
0
0
0
(
250 MHz, CDCl ): d 3.42–3.54 (m, 2H, H-6), 3.99 (br
3
s, 1H, H-4), 4.07–4.15 (dd, 1H, J5–6a 6.4, J5–6b 6.9 Hz,
H-5), 4.17–4.25 (m, 2H, H-2, H-3), 4.27–4.39 (m, 2H,
H–CH ), 4.30 (d, 1H, J 11.6 Hz, H–CH ), 4.37 (d, 1H,
0
0
+
0
2
2
J 11.8 Hz, H–CH ), 4.56 (d, 1H, J 11.3 Hz, H–CH ),
2
2
4
1
1
7
.63 (d, 1H, J 12.3 Hz, H–CH ), 4.78 (d, 1H, J
for C H NO : C, 72.60; H, 5.94; N, 2.12. Found: C,
73.02; H, 5.96; N, 2.11.
2
40 39
8
1.6 Hz, H–CH ), 4.82–4.92 (m, 2H, H–CH ), 4.96 (d,
2
2
H, J 11.3 Hz, H–CH ), 5.56 (d, 1H, J1–2 2.2 Hz, H-1),
2
.00–7.07 (ddd, 1H, J4
0
0
0:9, J
0
0
7:2, J 8:1 Hz,
0 0
3.12. 4-Cyanophenyl 2,3,4,6-tetra-O-benzyl-D-glucopyr-
anoside (5a)
–6
4 –5
4 –3
0
H-4 ), 7.12–7.43 (m, 22H, H-2Ar, H-3Ar, H-4Ar),
0
13
7
.78–7.84 (dd, 1H, J3
0
0
1:7, J
0 0
8:1 Hz, H-3 );
C
–5
3 –4
NMR (62.9 MHz, CDCl ): d 68.6 (C-6), 71.2 (C-5),
Treatment of 1a (0.5 g, 0.92 mmol), NaH (44 mg) and 2c
(0.17 g, 1.1 mmol) as described for 3a afforded 5a
(0.48 g; 82%) as an inseparable anomeric mixture; a/b
3
7
7
3.2, 73.5, 73.6, 74.9 (C–CH ), 75.2 (C-4), 76.1 (C-2),
2
0
0
8.6 (C-3), 97.2 (C-1), 117.0 (C-6 ), 121.5 (C-4 ), 125.4
0
13
(
C-3 ), 127.55, 127.58, 127.61, 127.63, 127.73, 127.74,
3:1 (determined by NMR). Representative C NMR
1
28.21, 128.26, 128.29, 128.31, 128.39 (C-2Ar, C-3Ar,
signals for a and b isomers.
a-Anomer: C NMR (62.9 MHz, CDCl ): d 68.1 (C-
0
13
C-4Ar), 133.8 (C-5 ), 137.8, 138.51, 138.54, 138.6 (C-
1
6
3
0
0
Ar), 140.7 (C-2 ), 150.1 (C-1 ); MALDI-TOFMS: m/z
6), 71.3 (C-5), 77.1 (C-4), 79.6 (C-2), 81.8 (C-3), 95.4 (C-
+
0
0
0
0
0
84.0 [M+Na] . Anal. Calcd for C H NO : C, 72.60;
1), 105.6 (C-4 ), 117.2 (C-2 , C-6 ), 133.9 (C-3 , C-5 ),
4
0
39
8
0
H, 5.94; N, 2.12. Found: C, 73.05; H, 5.97; N, 2.10.
159.9 (C-1 ).